Skip to content

Ascentage Pharma Group International Sustainability Reports

Ascentage Pharma Group International is a global, commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing targeted small-molecule therapies for cancers, hematological malignancies, and age-related diseases.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG00PGD9WR9

14 reports from 2019 to 2025